Drug Database
Back to search

France· FR:65700541

KOVALTRY 500 UI, poudre et solvant pour solution injectable

A octocog alfa product containing octocog alfa, registered in France by BAYER AG (ALLEMAGNE). The same ATC class is registered in 3 of our 19 countries.

ATC B02BD28

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedKOVALTRY 500 UI, poudre et solvant po…ATCB02BD28REGISTER NO.FR:65700541PACKS LISTED2CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about octocog alfaAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Octocog alfa is registered in 3 of 19 countries.

Countries holding a registration under ATC B02BD28 (octocog alfa), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 1 of them publish a price we can compare per daily dose
Search octocog alfa products by name

Octocog alfa · ATC B02BD28

3 / 19 countries

  • Franceprice
  • Germany
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
OCTOCOG ALFA
Manufacturer
BAYER AG (ALLEMAGNE)
Country
France (FR)
ATC code
B02BD28
ATC class
Octocog alfa
Defined daily dose
1 TSD, E
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

  • cip13
    3400955016618
    1 flacon(s) en verre + 1 seringue(s) préremplie(s) en verre de 2,5 ml + 1 adaptateur pour flacon + 1 nécessaire de ponction veineuse
  • cip13
    3400955027201
    1 flacon + 1 seringue préremplie (5 mL) + 1 adaptateur pour flacon + 1 nécessaire de ponction veineuse

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

4 interactions on record for octocog alfa.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check octocog alfa against other medicinesHow interaction checks work

Octocog alfa · interactions on record

4 records

  • 2 severe
  • 2 moderate

Most severe, free to view

  • CarfilzomibL01XG02severe
  • CarfilzomibL01XX45severe
  • PegvaliaseA16AB19moderate
  • EmicizumabB02BX06moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Octocog alfa in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All octocog alfa products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Germany · Recombinate
  • Iceland · Advate, Kovaltry
  • Italy · Recombinate
  • Liechtenstein · Advate, Kovaltry
  • Lithuania · Recombinate
  • Netherlands · Recombinate
  • Norway · Advate, Kovaltry

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d84ade57-80e3-443b-9ec8-b8d1f871891c
GET /v1/drugs/d84ade57-80e3-443b-9ec8-b8d1f871891c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "65700541",
  "date_amm": "2016-02-18",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/15/1076",
  "substance": "OCTOCOG ALFA",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "poudre et  solvant pour solution injectable",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about octocog alfa.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console